BNB Plus Corp. receives $1.2M order for LineaDNA

BNB Plus Corp. (BNBX) announced that it has received a $1.2M order for LineaDNA, representing the largest LineaDNA order in company history. The order is an acceleration of an existing customer’s annual purchasing cadence, consolidating what was originally planned as a two-year order cycle into an accelerated delivery schedule expected to be completed by May. The order was placed by a global manufacturer of in vitro diagnostics under an existing supply agreement. The company has previously announced LineaDNA purchases by this customer, including a $600,000 follow-on order in July 2025. This latest order reflects the customer’s decision to accelerate their procurement timeline, resulting in planned delivery within five months rather than the typical two-year cycle. Inclusive of its recent $1.2M order, the company expects to ship over $1.5M of LineaDNA to customers in the IVD and biotherapeutic markets in the first half of calendar year 2026.